Rexam introduces multidose preservative free eyedropper

Rexam Healthcare says its Novelia multidose preservative free eyedropper has numerous advantages both for patients and pharmaceutical companies.

Novelia multidose preservative free eye dropper

Rexam Healthcare says its Novelia multidose preservative free eyedropper has numerous advantages both for patients and pharmaceutical companies.

The company says the majority of multidose eyedroppers contain preservatives, the most well known being benzalkonium chloride. In ophthalmic chronic use this may damage the cornea.

The most widely used preservative-free ophthalmic solution is the unidose. However, this is expensive since it requires single use and is not convenient to use for the elderly and people with arthritis. It also requires pharmaceutical companies to install special filling lines.

Rexam's new device comprises a standard eye dropper bottle, a nozzle including a one-way valve (to prevent contamination inside the bottle and to distribute both liquid solutions and viscous products) and a tamper-evident cap.

The device is also able to calibrate droplets, which improves compliance.

For ophthalmic pharmaceutical companies, Rexam says Novelia offers major benefits: it is compatible with existing filling lines; it handles a wide range of drug viscosities; and it is easier to use for patients than unidose.

Novelia has been tested and confirmed content sterility and drop non-contamination for 28 days.




Featured Companies

Nemera (more information, website)